Disease ProgressionDisease-Free SurvivalSurvival RatePrognosisNeoplasm StagingTreatment OutcomeSurvival AnalysisRetrospective StudiesNeoplasm Recurrence, LocalBreast NeoplasmsCombined Modality TherapyKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisImmunohistochemistryRadiotherapy, AdjuvantProportional Hazards ModelsCell SurvivalTime FactorsFluorouracilRadiotherapy DosageNeoplasm InvasivenessCarcinoma, Squamous CellColorectal NeoplasmsCyclophosphamideMultivariate AnalysisAdenocarcinomaRecurrenceCarcinomaLiver NeoplasmsProspective StudiesCarcinoma, Ductal, BreastImmunoenzyme TechniquesPredictive Value of TestsGene Expression Regulation, NeoplasticReceptor, erbB-2Receptors, EstrogenNeoplasm MetastasisRisk FactorsAntineoplastic AgentsLung NeoplasmsCisplatinSurvivalCohort StudiesDrug Administration ScheduleNeoplasm GradingGraft SurvivalVincristineBone NeoplasmsDoxorubicinCell Line, TumorRemission InductionCarcinoma, Non-Small-Cell LungOvarian NeoplasmsSalvage TherapyProstatic NeoplasmsDisease Models, AnimalHIV InfectionsNeoadjuvant TherapyEtoposideCell ProliferationAge FactorsNeoplasm ProteinsMethotrexateHead and Neck NeoplasmsChemoradiotherapyReverse Transcriptase Polymerase Chain ReactionMutationCarcinoma, HepatocellularReceptors, ProgesteroneHIV-1CarboplatinBrain NeoplasmsAntibodies, MonoclonalPancreatic NeoplasmsApoptosisPrednisoneSignal TransductionRadiotherapyLymph NodesMelanomaPaclitaxelSarcomaLymphoma, Non-HodgkinCD4 Lymphocyte CountDeoxycytidineActuarial AnalysisRisk AssessmentHodgkin DiseaseAntineoplastic Agents, HormonalStomach NeoplasmsAntibodies, Monoclonal, HumanizedViral LoadTransplantation, AutologousFree RadicalsGene Expression ProfilingKidney Neoplasms